The effect of tacrolimus ointment and timolol solution in the treatment of post-acne erythema

Phase 3

• Conditions: Acne vulgaris.; Acne vulgaris; L70.0

• Registration Number: IRCT20151123025202N33
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Age above 18 years
Consent to participate in the study

Exclusion Criteria

History of allergy to tacrolimus and timolol
History of using anti-acne drugs within 3 months before the treatment process
Pregnant and lactating mothers
bronchial asthma,
severe COPD,
sinus bradycardia, 2nd and 3rd degree heart block and heart failure

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Erythema. Timepoint: Before treatment, at the end of week 4 and at the end of week 8 of treatment. Method of measurement: Take a picture of lesions and and compare based on Clinical Erythema Assessment scale by dermatologist.

Secondary Outcome Measures

Name	Time	Method
Side effects of itching, burning, scaling and redness. Timepoint: 4th and 8th week of treatment. Method of measurement: Clinical examination and asking the patient about complications.